There was a highly significant difference between the growth rates of E7/18 and E7/22 genomes (p<0.001, unpaired student t test) and a moderately significant difference between E7/18 and wild type at later time points (p<0.03, unpaired student t test; Fig 8).
Subsequent analysis of difference scores showed a moderately significant difference between groups (p = 0.087) (Table 2).
In this study, a moderately significant difference in detectable AFB1-albumin adduct levels was found between HBsAg-positive and negative adults, particularly in males.
For example, transcript isoforms that showed sex-differential abundances did not have a significant enrichment of differences in their internal cassette exons, or 5' exons, relative to all transcript isoforms, though a moderately significant difference was detected for 3' exons.
Comparison of the within-group differences over time revealed a significant difference between groups for the CarerQoL sum score (p = 0.033) and a moderately significant difference between groups for the CarerQoL-VAS (p = 0.060).
In addition, there were also moderately significant differences in the adduct detection rate depending on GSTM1-1 and GSTT1-1 genothees; the detection rate was higher in individuals with either GSTM1-1 null (43.0%) or GSTT1-1 null (44.2%) genotype than in those with GSTM1-1 (36.4%) or GSTT1-1 (35.9%) present.
Participants' agreement on the 5 repeated cases was moderately high, with no significant difference between the high fidelity physical simulation assessments (Phi 0.741) and the paper case simulation assessments (Phi 0.777, bootstrap SE 0.023, z = 1.58, P = 0.12).
Finally, the Dun test revealed a statistically significant difference between moderately and well differentiated tumour histological type, where the former showed higher levels of ST6Gal I activity, of tumour/healthy activity ratio and net increase of activity in tumour specimens (Table 2).
Among the 104 surviving women, the average survival period was 106.8 months for the preserved group, 88.9 months for the minimally impaired group, and 95.1 months for the moderately impaired group, with no significant difference in cumulative survival period among the three groups.
In colon cancer, although the survival curves for E2F4 iRAS >0 group and iRAS <0 groups are fairly separated, the statistical <span class="lh">difference is only moderately significant (P = 0.04).
In contrast to CS levels, the median ALP levels between moderately and severely destructive sites [PM (27.40 ng/ml) vs. the PSE group (37.05 ng/ml)] were not significantly different, although a significant difference was still observed between non-destructive to slightly destructive sites and moderately to severely destructive sites (p < 0.001).
